{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:30:06Z","timestamp":1791178206712,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2010,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Angiogenesis is a common finding in chronic inflammatory diseases; however, its role in multiple sclerosis (MS) is unclear. Central nervous system lesions from both MS and experimental autoimmune encephalomyelitis (EAE), the animal model of MS, contain T cells, macrophages and activated glia, which can produce pro-angiogenic factors. Previous EAE studies have demonstrated an increase in blood vessels, but differences between the different phases of disease have not been reported. Therefore we examined angiogenic promoting factors in MS and EAE lesions to determine if there were changes in blood vessel density at different stages of EAE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>In this series of experiments we used a combination of vascular casting, VEGF ELISA and immunohistochemistry to examine angiogenesis in experimental autoimmune encephalomyelitis (EAE). Using immunohistochemistry we also examined chronic active MS lesions for angiogenic factors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Vascular casting and histological examination of the spinal cord and brain of rats with EAE demonstrated that the density of patent blood vessels increased in the lumbar spinal cord during the relapse phase of the disease (p &lt; 0.05). We found an increased expression of VEGF by inflammatory cells and a decrease in the recently described angiogenesis inhibitor meteorin. Examination of chronic active human MS tissues demonstrated glial expression of VEGF and glial and blood vessel expression of the pro-angiogenic receptor VEGFR2. There was a decreased expression of VEGFR1 in the lesions compared to normal white matter.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These findings reveal that angiogenesis is intimately involved in the progression of EAE and may have a role in MS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-2094-7-95","type":"journal-article","created":{"date-parts":[[2011,1,5]],"date-time":"2011-01-05T19:40:22Z","timestamp":1294256422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions"],"prefix":"10.1186","volume":"7","author":[{"given":"Timothy J","family":"Seabrook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Littlewood-Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Brinkmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"P\u00f6llinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C","family":"Hiestand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,12,22]]},"reference":[{"key":"307_CR1","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","volume":"23","author":"M Sospedra","year":"2005","unstructured":"Sospedra M, Martin R: Immunology of multiple sclerosis. Annu Rev Immunol. 2005, 23: 683-747. 10.1146\/annurev.immunol.23.021704.115707.","journal-title":"Annu Rev Immunol"},{"key":"307_CR2","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1001\/archneur.62.10.1519","volume":"62","author":"EM Frohman","year":"2005","unstructured":"Frohman EM, Stuve O, Havrdova E, Corboy J, Achiron A, Zivadinov R, et al: Therapeutic considerations for disease progression in multiple sclerosis - Evidence, experience, and future expectations. Arch Neurol. 2005, 62: 1519-1530. 10.1001\/archneur.62.10.1519.","journal-title":"Arch Neurol"},{"key":"307_CR3","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1093\/brain\/awn118","volume":"131","author":"PL De Jager","year":"2008","unstructured":"De Jager PL, Rossin E, Pyne S, Tamayo P, Ottoboni L, Viglietta V, et al: Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8(low) cells. Brain. 2008, 131: 1701-1711. 10.1093\/brain\/awn118.","journal-title":"Brain"},{"key":"307_CR4","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1212\/01.wnl.0000294325.63006.f8","volume":"70","author":"PL De Jager","year":"2008","unstructured":"De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A: Integrating risk factors - HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis. Neurol. 2008, 70: 1113-1118.","journal-title":"Neurol"},{"key":"307_CR5","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1056\/NEJMra052130","volume":"354","author":"EM Frohman","year":"2006","unstructured":"Frohman EM, Racke MK, Raine CS: Medical progress: Multiple sclerosis - The plaque and its pathogenesis. New Engl J Med. 2006, 354: 942-955. 10.1056\/NEJMra052130.","journal-title":"New Engl J Med"},{"key":"307_CR6","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic BV: The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron. 2008, 57: 178-201. 10.1016\/j.neuron.2008.01.003.","journal-title":"Neuron"},{"key":"307_CR7","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/01.jnen.0000235119.52311.16","volume":"65","author":"S Hochmeister","year":"2006","unstructured":"Hochmeister S, Grundtner R, Bauer J, Engelhardt B, Lyck R, Gordon G, et al: Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol. 2006, 65: 855-865. 10.1097\/01.jnen.0000235119.52311.16.","journal-title":"J Neuropathol Exp Neurol"},{"key":"307_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/0006-8993(84)90249-X","volume":"302","author":"M Juhler","year":"1984","unstructured":"Juhler M, Barry DI, Offner H, Konat G, Klinken L, Paulson OB: Blood-Brain and Blood Spinal-Cord Barrier Permeability During the Course of Experimental Allergic Encephalomyelitis in the Rat. Brain Res. 1984, 302: 347-355. 10.1016\/0006-8993(84)90249-X.","journal-title":"Brain Res"},{"key":"307_CR9","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/S0002-9440(10)63232-4","volume":"164","author":"M Kerschensteiner","year":"2004","unstructured":"Kerschensteiner M, Stadelmann C, Buddeberg BS, Merkler D, Bareyre FM, Anthony DC, et al: Targeting experimental autoimmune encephalomyelitis lesions to a predetermined axonal tract system allows for refined behavioral testing in an animal model of multiple sclerosis. Am J Pathol. 2004, 164: 1455-1469.","journal-title":"Am J Pathol"},{"key":"307_CR10","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/5532","volume":"5","author":"CP Genain","year":"1999","unstructured":"Genain CP, Cannella B, Hauser SL, Raine CS: Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Medicine. 1999, 5: 170-175. 10.1038\/5532.","journal-title":"Nature Medicine"},{"key":"307_CR11","doi-asserted-by":"publisher","first-page":"1S","DOI":"10.1111\/j.1552-6569.2007.00128.x","volume":"17","author":"M Filippi","year":"2007","unstructured":"Filippi M, Bakshi R, Rovaris M, Comi G: MRI and multiple sclerosis: What happened in the last 10 years?. J Neuroimaging. 2007, 17: 1S-2S. 10.1111\/j.1552-6569.2007.00128.x.","journal-title":"J Neuroimaging"},{"key":"307_CR12","doi-asserted-by":"publisher","first-page":"5S","DOI":"10.1177\/1051228405283362","volume":"15","author":"R Bakshi","year":"2005","unstructured":"Bakshi R: Magnetic resonance imaging advances in multiple sclerosis. J Neuroimaging. 2005, 15: 5S-9S. 10.1177\/1051228405283362.","journal-title":"J Neuroimaging"},{"key":"307_CR13","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/brain\/awh007","volume":"127","author":"J Wuerfel","year":"2004","unstructured":"Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, Villringer A, et al: Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain. 2004, 127: 111-119. 10.1093\/brain\/awh007.","journal-title":"Brain"},{"key":"307_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1038\/nrn2175","volume":"8","author":"RK Jain","year":"2007","unstructured":"Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, Batchelor TT: Angiogenesis in brain tumours. Nature Reviews Neuroscience. 2007, 8: 610-622. 10.1038\/nrn2175.","journal-title":"Nature Reviews Neuroscience"},{"key":"307_CR15","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1093\/brain\/awm118","volume":"130","author":"V Rigau","year":"2007","unstructured":"Rigau V, Morin M, Rousset MC, de Bock F, Lebrun A, Coubes P, et al: Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy. Brain. 2007, 130: 1942-1956. 10.1093\/brain\/awm118.","journal-title":"Brain"},{"key":"307_CR16","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","volume":"28","author":"BV Zlokovic","year":"2005","unstructured":"Zlokovic BV: Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci. 2005, 28: 202-208. 10.1016\/j.tins.2005.02.001.","journal-title":"Trends Neurosci"},{"key":"307_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.jns.2003.10.016","volume":"217","author":"S Kirk","year":"2004","unstructured":"Kirk S, Frank JA, Karlik S: Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?. J Neurol Sci. 2004, 217: 125-130. 10.1016\/j.jns.2003.10.016.","journal-title":"J Neurol Sci"},{"key":"307_CR18","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/S0896-8411(03)00139-2","volume":"21","author":"SL Kirk","year":"2003","unstructured":"Kirk SL, Karlik SJ: VEGF and vascular changes in chronic neuroinflammation. J Autoimmun. 2003, 21: 353-363. 10.1016\/S0896-8411(03)00139-2.","journal-title":"J Autoimmun"},{"key":"307_CR19","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jneuroim.2009.01.009","volume":"209","author":"WA Roscoe","year":"2009","unstructured":"Roscoe WA, Welsh ME, Carter DE, Karlik SJ: VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE. J Neuroimmunol. 2009, 209: 6-15. 10.1016\/j.jneuroim.2009.01.009.","journal-title":"J Neuroimmunol"},{"key":"307_CR20","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/jnen\/61.10.914","volume":"61","author":"MA Proescholdt","year":"2002","unstructured":"Proescholdt MA, Jacobson S, Tresser N, Oldfield EH, Merrill MJ: Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats. J Neuropathol Exp Neurol. 2002, 61: 914-925.","journal-title":"J Neuropathol Exp Neurol"},{"key":"307_CR21","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.expneurol.2004.02.010","volume":"187","author":"SD Croll","year":"2004","unstructured":"Croll SD, Ransohoff RM, Cai N, Zhang Q, Martin FJ, Wei T, et al: VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol. 2004, 187: 388-402. 10.1016\/j.expneurol.2004.02.010.","journal-title":"Exp Neurol"},{"key":"307_CR22","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.jns.2005.11.006","volume":"243","author":"JJ Su","year":"2006","unstructured":"Su JJ, Osoegawa M, Matsuoka T, Minohara M, Tanaka M, Ishizu T, et al: Upregulation of vascular growth factors in multiple sclerosis: Correlation with MRI findings. J Neurol Sci. 2006, 243: 21-30. 10.1016\/j.jns.2005.11.006.","journal-title":"J Neurol Sci"},{"key":"307_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neulet.2009.12.059","volume":"470","author":"JE Holley","year":"2010","unstructured":"Holley JE, Newcombe J, Whatmore JL, Gutowski NJ: Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neurosci Lett. 2010, 470: 65-70. 10.1016\/j.neulet.2009.12.059.","journal-title":"Neurosci Lett"},{"key":"307_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/nbm.1007","volume":"19","author":"C Berger","year":"2006","unstructured":"Berger C, Hiestand P, Kindler-Baumann D, Rudin M, Rausch M: Analysis of lesion development during inflammation and remission in a rat model of experimental autoimmune encephalomyelitis by visulalization of macrophage infiltration, demyelination and blood brain-barrier damage. NMR Biomed. 2006, 19: 101-107. 10.1002\/nbm.1007.","journal-title":"NMR Biomed"},{"key":"307_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1046\/j.1365-2818.1997.1340694.x","volume":"185","author":"T Hildebrand","year":"1997","unstructured":"Hildebrand T, Ruegsegger P: A new method for the model-independent assessment of thickness in three-dimensional images. Journal of Microscopy-Oxford. 1997, 185: 67-75. 10.1046\/j.1365-2818.1997.1340694.x.","journal-title":"Journal of Microscopy-Oxford"},{"key":"307_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/1352458508096006","volume":"15","author":"M Rausch","year":"2009","unstructured":"Rausch M, Tofts PS, Lervik P, Walmsley AR, Mir A, Schubart A, et al: Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f*. Multiple Sclerosis. 2009, 15: 16-27. 10.1177\/1352458508096006.","journal-title":"Multiple Sclerosis"},{"key":"307_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1227\/00006123-199308000-00015","volume":"33","author":"I Koyanagi","year":"1993","unstructured":"Koyanagi I, Tator CH, Piepmeier JM, Lea PJ, Turnbull IM: 3-Dimensional Analysis of the Vascular System in the Rat Spinal-Cord with Scanning Electron-Microscopy of Vascular Corrosion Casts .1. Normal Spinal-Cord. Neurosurgery. 1993, 33: 277-284. 10.1227\/00006123-199308000-00015.","journal-title":"Neurosurgery"},{"key":"307_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/labinvest.3780036","volume":"80","author":"KC Williams","year":"2000","unstructured":"Williams KC, Zhao WG, Politopoulou G, Male D, Hickey WF: Inhibition of experimental allergic encephalomyelitis with an antibody that recognizes a novel antigen expressed on lymphocytes, endothelial cells, and microglia. Lab Invest. 2000, 80: 313-326.","journal-title":"Lab Invest"},{"key":"307_CR29","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1365-3083.2007.01914_1.x","volume":"65","author":"E Tham","year":"2007","unstructured":"Tham E, Gielen AW, Khademi M, Martin C, Piehl F: Decreased expression of VEGF-A in rat experimental autoimmune encephalomyelitis and in cerebrospinal fluid mononuclear cells from patients with multiple sclerosis. Scand J Immunol. 2007, 65: 310-10.1111\/j.1365-3083.2007.01914_1.x.","journal-title":"Scand J Immunol"},{"key":"307_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1097\/00005072-199906000-00006","volume":"58","author":"MA Proescholdt","year":"1999","unstructured":"Proescholdt MA, Heiss JD, Walbridge S, Muhlhauser J, Capogrossi MC, Oldfield EH, et al: Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol. 1999, 58: 613-627. 10.1097\/00005072-199906000-00006.","journal-title":"J Neuropathol Exp Neurol"},{"key":"307_CR31","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/glia.20600","volume":"56","author":"JA Park","year":"2008","unstructured":"Park JA, Lee HS, Ko KJ, Park SY, Kim JH, Choe G, et al: Meteorin regulates angiogenesis at the gliovascular interface. Glia. 2008, 56: 247-258. 10.1002\/glia.20600.","journal-title":"Glia"},{"key":"307_CR32","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1096\/fasebj.11.6.9194526","volume":"11","author":"JR Jackson","year":"1997","unstructured":"Jackson JR, Seed MP, Kircher CH, Willoughby DA, Winkler JD: The codependence of angiogenesis and chronic inflammation. FASEB J. 1997, 11: 457-465.","journal-title":"FASEB J"},{"key":"307_CR33","doi-asserted-by":"publisher","first-page":"4618","DOI":"10.4049\/jimmunol.172.7.4618","volume":"172","author":"F Mor","year":"2004","unstructured":"Mor F, Quintana FJ, Cohen IR: Angiogenesis-inflammation cross-talk: Vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol. 2004, 172: 4618-4623.","journal-title":"J Immunol"},{"key":"307_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10555-007-9108-5","volume":"27","author":"DM Noonan","year":"2008","unstructured":"Noonan DM, Barbaro ADL, Vannini N, Mortara L, Albini A: Inflammation, inflammatory cells and angiogenesis: decisions and indecisions. Cancer Metastasis Rev. 2008, 27: 31-40. 10.1007\/s10555-007-9108-5.","journal-title":"Cancer Metastasis Rev"},{"key":"307_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1189\/jlb.0806517","volume":"81","author":"SH Jeon","year":"2007","unstructured":"Jeon SH, Chae BC, Kim HA, Seo GY, Seo DW, Chun GT, et al: Mechanisms underlying TGF-beta 1-induced expression of VEGF and Flk-1 in mouse macrophages and their implications for angiogenesis. J Leukoc Biol. 2007, 81: 557-566. 10.1189\/jlb.0806517.","journal-title":"J Leukoc Biol"},{"key":"307_CR36","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/S0002-9440(10)65601-5","volume":"153","author":"M Xiong","year":"1998","unstructured":"Xiong M, Elson G, Legarda D, Leibovich SJ: Production of vascular endothelial growth factor by murine macrophages - Regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol. 1998, 153: 587-598.","journal-title":"Am J Pathol"},{"key":"307_CR37","first-page":"1","volume":"79","author":"A Minagar","year":"2007","unstructured":"Minagar A, Carpenter A, Alexander JS: The destructive alliance: Interactions of leukocytes, cerebral endothelial cells, and the immune cascade in pathogenesis of multiple sclerosis. Neurobiology of Multiple Sclerosis. 2007, 79: 1-11. full_text.","journal-title":"Neurobiology of Multiple Sclerosis"},{"key":"307_CR38","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1038\/nature04481","volume":"438","author":"DA Greenberg","year":"2005","unstructured":"Greenberg DA, Jin KL: From angiogenesis to neuropathology. Nature. 2005, 438: 954-959. 10.1038\/nature04481.","journal-title":"Nature"},{"key":"307_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-2094-5-20","volume":"5","author":"AM Mueller","year":"2008","unstructured":"Mueller AM, Pedre X, Stempfl T, Kleiter I, Couillard-Despres S, Aigner L, et al: Novel role for SLPI in MOG-induced EAE revealed by spinal cord expression analysis. J Neuroinflamm. 2008, 5: 20-10.1186\/1742-2094-5-20.","journal-title":"J Neuroinflamm"},{"key":"307_CR40","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1002\/bies.20092","volume":"26","author":"E Storkebaum","year":"2004","unstructured":"Storkebaum E, Lambrechts D, Carmeliet P: VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays. 2004, 26: 943-954. 10.1002\/bies.20092.","journal-title":"Bioessays"},{"key":"307_CR41","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.brainresbull.2007.11.018","volume":"76","author":"DP McCloskey","year":"2008","unstructured":"McCloskey DP, Tana MH, Scharfman HE: Modulation of vascular endothelial growth factor (VEGF) expression in motor neurons and its electrophysiological effects. Brain Res Bull. 2008, 76: 36-44. 10.1016\/j.brainresbull.2007.11.018.","journal-title":"Brain Res Bull"},{"key":"307_CR42","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00004647-200204000-00002","volume":"22","author":"ZG Zhang","year":"2002","unstructured":"Zhang ZG, Zhang L, Tsang W, Soltanian-Zadeh H, Morris D, Zhang R, Goussev A, Powers C, Yeich T, Chopp M: Correlation of VEGF and angiopoietin expression with disruption of Blood-Brain Barrier and angiogenesis after focal cerebral ischemia. J Cereb Blood Flow Metab. 2002, 22: 379-92. 10.1097\/00004647-200204000-00002.","journal-title":"J Cereb Blood Flow Metab"},{"key":"307_CR43","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.4049\/jimmunol.177.8.5574","volume":"177","author":"AT Argaw","year":"2006","unstructured":"Argaw AT, Zhang YT, Snyder BJ, Zhao ML, Kopp N, Lee SC, et al: IL-1 beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol. 2006, 177: 5574-5584.","journal-title":"J Immunol"},{"key":"307_CR44","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.4161\/cc.7.16.6442","volume":"7","author":"P Knizetova","year":"2008","unstructured":"Knizetova P, Ehrmann J, Hlobilkova A, Vancova I, Kalita O, Kolar Z, et al: Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through the VEGF-VEGFR2 (KDR) interplay. Cell Cycle. 2008, 7: 2553-2561. 10.4161\/cc.7.16.6442.","journal-title":"Cell Cycle"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-7-95.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T04:48:57Z","timestamp":1630471737000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-7-95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["307"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-7-95","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"31 August 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2010","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2010","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"95"}}